Serum Soluble VCAM-1, IL-8, and IL-1β as Inflammatory Biomarkers in Coronary Atherosclerosis A Case–Control Study

Authors

  • Amer A. Khaleel l*, Radhwan Sh. Uso 2

Abstract

Background: Coronary atherosclerosis is increasingly recognized as a chronic inflammatory disease of 
the arterial wall; however, the simultaneous contribution of the endothelial adhesion molecule soluble 
VCAM-1 (sVCAM-1) and the upstream pro-inflammatory cytokines IL-8 and IL-1β to disease 
discrimination in Middle Eastern populations remains under-investigated. This study aimed to examine 
the correlation of these specific immunological biomarkers with clinical metabolic profiles and 
conventional inflammatory markers (such as hs-CRP and leukocyte counts) to evaluate their simultaneous 
contribution to disease discrimination and to determine their combined clinical utility in reflecting the 
atherosclerotic burden within a Middle Eastern population.  
Methods: a case–control study enrolled 150 participants 100 patients with angiographically confirmed 
coronary atherosclerosis and age-matched healthy controls in whom demographic, clinical, and metabolic 
profiles were recorded and serum sVCAM-1, IL-8, and IL-1β were quantified by enzyme-linked 
immunosorbent assay alongside hs-CRP, total leukocyte count, and neutrophil count.  
Results: Atherosclerosis cases exhibited markedly elevated with significant difference sVCAM-1 , IL-8, 
and IL-1β compared with controls (all p < 0.001), and were also older, more frequently male, hypertensive, 
smokers, and dyslipidemic, with higher hs-CRP and leukocyte counts.  
Conclusions: Collectively, these findings indicate that sVCAM-1, IL-8, and IL-1β are substantially 
elevated in coronary atherosclerosis and meaningfully enhance inflammatory characterization beyond 
conventional cardiovascular risk factors and hs-CRP alone, supporting their combined clinical utility as 
candidate biomarkers of atherosclerotic burden.

Downloads

Published

2026-11-15

Issue

Section

Articles

How to Cite

1.
Amer A. Khaleel l*, Radhwan Sh. Uso 2. Serum Soluble VCAM-1, IL-8, and IL-1β as Inflammatory Biomarkers in Coronary Atherosclerosis A Case–Control Study. Sawa Med. J. [Internet]. 2026 Nov. 15 [cited 2026 Nov. 17];2(4):1287-300. Available from: https://smj.sawauniversity.edu.iq/article/view/927